- Home
- XBIO vs ONFO Comparison
XBIO vs ONFO Comparison
Compare XBIO & ONFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBIO
- ONFO
- Stock Information
- Founded
- XBIO N/A
- ONFO 2018
- Country
- XBIO United States
- ONFO United States
- Employees
- XBIO N/A
- ONFO N/A
- Industry
- XBIO Biotechnology: Pharmaceutical Preparations
- ONFO Computer Software: Programming Data Processing
- Sector
- XBIO Health Care
- ONFO Technology
- Exchange
- XBIO Nasdaq
- ONFO Nasdaq
- Market Cap
- XBIO 5.8M
- ONFO 6.2M
- IPO Year
- XBIO N/A
- ONFO 2022
- Fundamental
- Price
- XBIO $2.67
- ONFO $0.93
- Analyst Decision
- XBIO Hold
- ONFO
- Analyst Count
- XBIO 1
- ONFO 0
- Target Price
- XBIO N/A
- ONFO N/A
- AVG Volume (30 Days)
- XBIO 6.9K
- ONFO 31.1K
- Earning Date
- XBIO 03-18-2025
- ONFO 05-20-2025
- Dividend Yield
- XBIO N/A
- ONFO N/A
- EPS Growth
- XBIO N/A
- ONFO N/A
- EPS
- XBIO N/A
- ONFO N/A
- Revenue
- XBIO $2,500,284.00
- ONFO $6,590,171.00
- Revenue This Year
- XBIO N/A
- ONFO $133.59
- Revenue Next Year
- XBIO $27.78
- ONFO N/A
- P/E Ratio
- XBIO N/A
- ONFO N/A
- Revenue Growth
- XBIO N/A
- ONFO 29.25
- 52 Week Low
- XBIO $2.26
- ONFO $0.39
- 52 Week High
- XBIO $5.20
- ONFO $1.88
- Technical
- Relative Strength Index (RSI)
- XBIO 27.60
- ONFO 40.53
- Support Level
- XBIO $3.25
- ONFO $0.61
- Resistance Level
- XBIO $3.43
- ONFO $1.38
- Average True Range (ATR)
- XBIO 0.24
- ONFO 0.11
- MACD
- XBIO -0.08
- ONFO -0.03
- Stochastic Oscillator
- XBIO 25.63
- ONFO 41.34
About XBIO Xenetic Biosciences Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immune-oncology technologies addressing cancers. The company is also engaged in progressing XCART, a personalized CAR T platform technology. The Company's DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which have been implicated in cancer progression and resistance to cancer treatments. The company also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin-resistant endometrial cancer.
About ONFO Onfolio Holdings Inc.
Onfolio Holdings Inc actively manages small online businesses that operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by existing teams or have management teams largely in place.